Thomas Coleman - Scotts Miracle Chief Financial Officer, Executive Vice President
| SMG Stock | USD 77.86 2.04 2.69% |
President
Mr. Thomas R. Coleman is Chief Financial Officer, Executive Vice President of the Company. Prior to this appointment, Mr. Coleman had served as Senior Vice President, Global Finance Operations and Enterprise Performance Management Analytics for The Scotts Company LLC, a whollyowned subsidiary of Scotts MiracleGro, since January 2011. Previously, Mr. Coleman served as interim principal financial officer of Scotts MiracleGro between February 2013 and March 2013. Prior to 2012, Mr. Coleman held various managerial roles at the Company. since 2014.
| Age | 50 |
| Tenure | 10 years |
| Address | 14111 Scottslawn Road, Marysville, OH, United States, 43041 |
| Phone | 937 644 0011 |
| Web | https://scottsmiraclegro.com |
Scotts Miracle Management Efficiency
The company has Return on Asset of 0.0706 % which means that on every $100 spent on assets, it made $0.0706 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4764) %, meaning that it generated no profit with money invested by stockholders. Scotts Miracle's management efficiency ratios could be used to measure how well Scotts Miracle manages its routine affairs as well as how well it operates its assets and liabilities. The Scotts Miracle's current Return On Capital Employed is estimated to increase to 0.17, while Return On Tangible Assets are forecasted to increase to (0.01). At this time, Scotts Miracle's Other Assets are most likely to increase significantly in the upcoming years. The Scotts Miracle's current Intangibles To Total Assets is estimated to increase to 0.39, while Non Current Assets Total are projected to decrease to roughly 1.3 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Gregory Friedman | Corteva | 52 | |
| Andrew Sandifer | FMC Corporation | 54 | |
| Joseph Podwika | Nutrien | 56 | |
| Mark Isaacson | The Mosaic | 62 | |
| Kobi Altman | ICL Israel Chemicals | 52 | |
| Miri Mishor | ICL Israel Chemicals | 60 | |
| Douglas Barnard | CF Industries Holdings | 65 | |
| Anthony Hendrix | American Vanguard | 53 | |
| Michael Reilly | FMC Corporation | 60 | |
| Sam Eathington | Corteva | 52 | |
| Steven Douglas | Nutrien | N/A | |
| Anantha Desikan | ICL Israel Chemicals | 53 | |
| E Stone | Intrepid Potash | 58 | |
| Karen Swager | The Mosaic | 53 | |
| Ido Lilian | ICL Israel Chemicals | 60 | |
| Leslie ODonoghue | Nutrien | 55 | |
| Clint Freeland | The Mosaic | 56 | |
| David Anderson | Corteva | 71 | |
| Brent Poohkay | Nutrien | 54 | |
| Susan Menzel | CF Industries Holdings | 59 | |
| Corrine Ricard | The Mosaic | 61 | |
Management Performance
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0706 |
Scotts Miracle Gro Leadership Team
Elected by the shareholders, the Scotts Miracle's board of directors comprises two types of representatives: Scotts Miracle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scotts. The board's role is to monitor Scotts Miracle's management team and ensure that shareholders' interests are well served. Scotts Miracle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scotts Miracle's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Hagedorn, Chairman of the Board, Chief Executive Officer | ||
| Brian Finn, Independent Director | ||
| Ivan Esq, Gen VP | ||
| Christopher Hagedorn, Division President | ||
| Dave Swihart, Senior Development | ||
| Matthew Garth, Ex CFO | ||
| Nancy Mistretta, Independent Director | ||
| Thomas Coleman, Chief Financial Officer, Executive Vice President | ||
| Scott Hendrick, Senior Chain | ||
| Michael Lukemire, President, Chief Operating Officer | ||
| Cory Miller, Interim Chief Financial Officer, Senior Vice President | ||
| Dimiter Todorov, General EVP | ||
| Julie DeMuesy, Chief VP | ||
| Thomas Kelly, Independent Director | ||
| Thomas Crabtree, Senior Sales | ||
| John Vines, Lead Independent Director | ||
| Ivan Smith, Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary | ||
| Adam Hanft, Independent Director | ||
| Aimee DeLuca, Senior Relations | ||
| Stephen Johnson, Independent Director | ||
| Phil Jones, Senior Sales | ||
| Nathan Baxter, Executive COO | ||
| David Evans, Independent Director | ||
| Josh Peoples, VP Officer | ||
| Denise Stump, Executive Vice President - Global Human Resources, Chief Ethics Officer | ||
| Katherine Littlefield, Director | ||
| Gerald Volas, Independent Director | ||
| James King, Executive Vice President Chief Communications Officer | ||
| Peter Shumlin, Independent Director |
Scotts Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scotts Miracle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0706 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.31) % | |||
| Current Valuation | 6.43 B | |||
| Shares Outstanding | 56.82 M | |||
| Shares Owned By Insiders | 25.07 % | |||
| Shares Owned By Institutions | 78.10 % | |||
| Number Of Shares Shorted | 5.03 M | |||
| Price To Earning | 6.67 X |
Currently Active Assets on Macroaxis
When determining whether Scotts Miracle Gro is a strong investment it is important to analyze Scotts Miracle's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Scotts Miracle's future performance. For an informed investment choice regarding Scotts Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scotts Miracle Gro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scotts Miracle. If investors know Scotts will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scotts Miracle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.961 | Dividend Share 2.64 | Earnings Share (0.61) | Revenue Per Share 62.548 | Quarterly Revenue Growth 0.107 |
The market value of Scotts Miracle Gro is measured differently than its book value, which is the value of Scotts that is recorded on the company's balance sheet. Investors also form their own opinion of Scotts Miracle's value that differs from its market value or its book value, called intrinsic value, which is Scotts Miracle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scotts Miracle's market value can be influenced by many factors that don't directly affect Scotts Miracle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scotts Miracle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scotts Miracle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scotts Miracle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.